Amustaline (BioDeep_00000176031)

   

human metabolite blood metabolite


代谢物信息卡片


(N,N-Bis(2-chloroethyl))-2-aminoethyl-3-((acridin-9-yl)amino)propionate

化学式: C22H25Cl2N3O2 (433.132373)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCC(=O)OCCN(CCCl)CCCl
InChI: InChI=1S/C22H25Cl2N3O2/c23-10-13-27(14-11-24)15-16-29-21(28)9-12-25-22-17-5-1-3-7-19(17)26-20-8-4-2-6-18(20)22/h1-8H,9-16H2,(H,25,26)

描述信息

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

同义名列表

7 个代谢物同义名

(N,N-Bis(2-chloroethyl))-2-aminoethyl-3-((acridin-9-yl)amino)propionate; 2-[bis(2-chloroethyl)amino]ethyl 3-[(acridin-9-yl)amino]propanoate; 2-[bis(2-chloroethyl)amino]ethyl 3-(acridin-9-ylamino)propanoate; S-303 Compound; S 303 Compound; S303 Compound; Amustaline



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Cissé Sow, Amélie Bouissou, Yvette A Girard, Gurvani B Singh, Lotfi Bounaadja, Jean-Marc Payrat, Delphine Haas, Hervé Isola, Marion C Lanteri, Peter Bringmann, Philippe Grellier. Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction. Transfusion. 2022 05; 62(5):1073-1083. doi: 10.1111/trf.16867. [PMID: 35385146]
  • M Aubry, A Laughhunn, F Santa Maria, M C Lanteri, A Stassinopoulos, D Musso. Amustaline (S-303) treatment inactivates high levels of Chikungunya virus in red-blood-cell components. Vox sanguinis. 2018 Apr; 113(3):232-241. doi: 10.1111/vox.12626. [PMID: 29314033]
  • Veronika Brixner, Arndt-Holger Kiessling, Katharina Madlener, Markus M Müller, Johannes Leibacher, Sarah Dombos, Iuliia Weber, Hans-Ulrich Pfeiffer, Christof Geisen, Michael Schmidt, Reinhard Henschler, Anne North, Norman Huang, Nina Mufti, Anna Erickson, Christine Ernst, Salvador Rico, Richard J Benjamin, Laurence M Corash, Erhard Seifried. Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery. Transfusion. 2018 04; 58(4):905-916. doi: 10.1111/trf.14528. [PMID: 29498049]
  • Maite Aubry, Andrew Laughhunn, Felicia Santa Maria, Marion C Lanteri, Adonis Stassinopoulos, Didier Musso. Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione. Transfusion. 2017 12; 57(12):2888-2896. doi: 10.1111/trf.14318. [PMID: 28921542]
  • Anne North, Vic Ciaravino, Nina Mufti, Laurence Corash. Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment. Transfusion. 2011 Oct; 51(10):2208-18. doi: 10.1111/j.1537-2995.2011.03132.x. [PMID: 21985050]
  • P Chakrabarty, S Rudra, M M Hoque. Update of pathogen reduction technology for therapeutic plasma. Mymensingh medical journal : MMJ. 2010 Apr; 19(2):308-11. doi: NULL. [PMID: 20395932]